Pharmacological and Combination Interventions...

Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/n ...  Show more

Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclos ...  Show more

Listen in as experts discuss the latest updates in AFib management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963752?src=mkm_podcast_addon_963752 

Send us Fan MailIn this episode, we discuss the clinical manifestations, diagnosis and management of peripheral arterial disease. Our medicine minute focuses on emerging evidence for the use of Rivaroxaban following the release of the COMPASS trial in 2020. Written by: Dr. Palki ...  Show more

With progressing CKD & HFrEF, what GDMT medications can you start, continue or stop? What does the data on hydralazine/isosorbide tell us and what does it NOT tell us? What are the pros and cons of starting GDMT inpatient versus outpatient? Do you still keep patients on GDMT once ...  Show more

Hear from experts about pragmatic implementation strategies for the primary care setting, including one practice’s key lessons learned from putting them into action. Panelists include Virna Little, PsyD, LCSW-r, SAP, CCM, Daniel Miller, MD and Allison Dubois, MPH. For more about ...  Show more